BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 3:23:00 PM | Browse: 902 | Download: 713
Publication Name World Journal of Radiology
Manuscript ID 8015
Country United Kingdom
Received
2013-12-11 17:56
Peer-Review Started
2013-12-11 18:56
To Make the First Decision
2014-01-08 14:38
Return for Revision
2014-01-09 10:58
Revised
Second Decision
2014-05-08 17:39
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-05-08 17:53
Articles in Press
2014-05-23 12:36
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-06-17 20:29
Publish the Manuscript Online
2014-06-28 15:27
ISSN 1949-8470 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Neuroimaging
Manuscript Type Review
Article Title Neuroimaging in Huntington’s disease
Manuscript Source Invited Manuscript
All Author List Flavia Niccolini and Marios Politis
Funding Agency and Grant Number
Corresponding Author Marios Politis, MD, MSc, PhD, Senior Clinical Lecturer, Head of the Neurodegeneration Imaging Group, Department of Clinical Neuroscience, King’s College London, 16 De Crespigny Park, London SE5 8AF, United Kingdom. marios.politis@kcl.ac.uk
Key Words Huntington’s disease; Premanifest Huntington’s disease gene carriers; Functional magnetic resonance imaging; Magnetic resonance imaging; Positron emission tomography
Core Tip Huntington’s disease (HD) is a hereditary and fatal neurodegenerative disorder. Although advances in genetics allow identification of individuals carrying the HD gene, much is still unknown about the mechanisms underlying the development of overt clinical symptoms and the transitional period between premanifestation and manifestation of the disease. Neuroimaging techniques such as magnetic resonance imaging and positron emission tomography may be a suitable biomarker for monitoring disease progression in HD and for assessing the efficacy of future disease modifying therapies. In this article, we provide an overview of the findings from neuroimaging techniques in HD.
Publish Date 2014-06-28 15:27
Citation Niccolini F, Politis M. Neuroimaging in Huntington’s disease. World J Radiol 2014; 6(6): 301-312
URL http://www.wjgnet.com/1949-8470/full/v6/i6/301.htm
DOI http://dx.doi.org/10.4329/wjr.v6.i6.301
Full Article (PDF) WJR-6-301.pdf
Full Article (Word) WJR-6-301.doc
Manuscript File 8015-Review.docx
Answering Reviewers 8015-Answering reviewers.pdf
Copyright License Agreement 8015-Copyright assignment.pdf
Peer-review Report 8015-Peer review(s).pdf
Scientific Editor Work List 8015-Scientific editor work list.pdf